Kleem Chaudhary

Corporate Officer/Principal at CHECKMATE PHARMACEUTICALS, INC.

48 year

Health Technology

Consumer Services

Profile

Kleem Chaudhary is currently the President, Chief Executive Officer & Director at Hyku Biosciences, Inc. He is also the Chief Business Officer at Checkmate Pharmaceuticals, Inc. and the Chief Operating Officer at Redona Therapeutics, Inc. Previously, Dr. Chaudhary worked as the Director-Oncology Division at Novartis AG from 2009 to 2016.
He then served as the Senior Director-Business Development & Licensing at Takeda Pharmaceutical Co., Ltd.
from 2016 to 2018.
After that, he was the Head-Business Development & Licensing at Biogen, Inc. from 2018 to 2019.
Dr. Chaudhary holds a doctorate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from The University of Winnipeg.

Kleem Chaudhary active positions

Companies	Position	Start
CHECKMATE PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/11/2019
Redona Therapeutics, Inc. Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.	Chief Operating Officer	-

All active positions of Kleem Chaudhary

Former positions of Kleem Chaudhary

Companies	Position	End
BIOGEN INC.	Corporate Officer/Principal	01/10/2019
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Corporate Officer/Principal	01/01/2018
NOVARTIS AG	Corporate Officer/Principal	01/05/2016

See the detail of Kleem Chaudhary's experience

Training of Kleem Chaudhary

The University of Winnipeg	Undergraduate Degree
The University of North Carolina at Chapel Hill	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kleem Chaudhary's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
BIOGEN INC.	Health Technology
TAKEDA PHARMACEUTICAL COMPANY LIMITED	Health Technology
NOVARTIS AG	Health Technology

Private companies	2
Checkmate Pharmaceuticals, Inc. Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA.	Health Technology
Redona Therapeutics, Inc. Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA.	Health Technology